The purpose of this study is to determine the effects (good and bad) of giving a drug called pentoxifylline to patients with acute pancreatitis, to see if it can improve blood tests associated with inflammation (tissue damage). Pentoxifylline is approved by the US Food and Drug Administration (FDA) for treatment of circulation problems, but its use in this study is investigational, which means that the FDA has not approved it for the treatment of pancreatitis. However, the FDA has allowed the use of pentoxifylline in this research study.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in C-Reactive Protein (CRP)
Timeframe: baseline, Day 1, Day 3
Change in Tumor Necrosis Factor (TNF)-Alpha
Timeframe: baseline, Day 1, Day 3
Change in Interleukin (IL) IL-6
Timeframe: baseline, Day 1, Day 3
Changes in Interleukin (IL) IL-8
Timeframe: baseline, Day 1, Day 3